Merck, Glenmark Avoid Trial With Zetia Patent Deal
On the cusp of trial, Merck & Co. and Glenmark Pharmaceuticals Inc. have resolved a lawsuit over a patent for Merck's blockbuster cholesterol drug Zetia, with Glenmark getting permission to launch...To view the full article, register now.
Already a subscriber? Click here to view full article